- Home
- SMX vs SILO Comparison
SMX vs SILO Comparison
Compare SMX & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMX
- SILO
- Stock Information
- Founded
- SMX N/A
- SILO 2010
- Country
- SMX Ireland
- SILO United States
- Employees
- SMX N/A
- SILO 3
- Industry
- SMX Industrial Machinery/Components
- SILO Apparel
- Sector
- SMX Technology
- SILO Consumer Discretionary
- Exchange
- SMX Nasdaq
- SILO Nasdaq
- Market Cap
- SMX 6.7M
- SILO 6.3M
- IPO Year
- SMX N/A
- SILO N/A
- Fundamental
- Price
- SMX $4.28
- SILO $0.63
- Analyst Decision
- SMX
- SILO
- Analyst Count
- SMX 0
- SILO 0
- Target Price
- SMX N/A
- SILO N/A
- AVG Volume (30 Days)
- SMX 1.3M
- SILO 593.7K
- Earning Date
- SMX 01-01-0001
- SILO 08-13-2025
- Dividend Yield
- SMX N/A
- SILO N/A
- EPS Growth
- SMX N/A
- SILO N/A
- EPS
- SMX N/A
- SILO N/A
- Revenue
- SMX N/A
- SILO $72,102.00
- Revenue This Year
- SMX N/A
- SILO $1.86
- Revenue Next Year
- SMX N/A
- SILO N/A
- P/E Ratio
- SMX N/A
- SILO N/A
- Revenue Growth
- SMX N/A
- SILO N/A
- 52 Week Low
- SMX $3.85
- SILO $0.41
- 52 Week High
- SMX $5,925.93
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- SMX 30.72
- SILO 45.96
- Support Level
- SMX $4.75
- SILO $0.60
- Resistance Level
- SMX $5.74
- SILO $0.70
- Average True Range (ATR)
- SMX 0.99
- SILO 0.06
- MACD
- SMX 0.55
- SILO -0.01
- Stochastic Oscillator
- SMX 7.67
- SILO 41.76
About SMX SMX (Security Matters) Public Limited Company
SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.